Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Kisspeptin

Kisspeptin KISSPEPTIN Kisspeptins and Precursor Protein The KISS1 gene encodes prepro-kisspeptin, the 145 amino acid kisspeptin precursor. The cleavage products from prepro-kisspeptin are known as kisspeptins and these peptides of various lengths all include a

Kisspeptin

KISSPEPTIN

Kisspeptins and Precursor Protein

The KISS1 gene encodes prepro-kisspeptin, the 145 amino acid kisspeptin precursor. The cleavage products from prepro-kisspeptin are known as kisspeptins and these peptides of various lengths all include an Arg-Phe-NH2 motif at the carboxy-terminus. The decapeptide, kisspeptin-10, possesses the minimal peptide length to bind and activate KISS1R. The most abundant cleavage product is the 54 amino acid isoform known as kisspeptin-54 (KP54) or commonly referred to as kisspeptin. Less common isoforms include kisspeptin-14 (KP14), kisspeptin-13 (KP13) and kisspeptin-10 (KP10). In addition, the mammalian sequence of kisspeptin-54 is named kisspeptin1 where as another form occurs in non-mammalian organisms that is called kisspeptin2 (2).

Regulation of the HPG Axis and Puberty

The KISS1 system plays a vital role in the regulation of reproduction and puberty. The system signals increased gonadotrophin secretion during puberty and establishes mammalian reproductive function and regulation of the hypothalamic-pituitary-gonadal (HPG) axis. By stimulating release of endogenous GnRH, kisspeptin stimulates the secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary gland. In turn, this results in the release of sex steroids from the gonads. KISS1 expression increases abruptly at the time of puberty, which suggests that kisspeptin signaling is involved in triggering the onset of puberty. In addition, kisspeptin may contribute to generating preovulatory gonadotropin surge in females (4). Given that kisspeptin plays a key role in regulating reproduction, the kisspeptin signaling pathway is a therapeutic target in reproductive disorders.

Role in Metabolism

More recently, kisspeptin was shown to play a part in glucose homeostasis, locomotor activity and body weight control (4). A tri-hormonal regulatory circuit exists between pancreatic α-cells, hepatocytes and β-cells. Glucagon, produced by α-cells in the Islets of Langerhans, stimulates cAMP-PKA signaling. In turn, this signaling up-regulates transcription of the gluconeogenic gene program and of KISS1. This leads to increased production of glucose and hepatic glucose output, and to the production of kisspeptin1. Glucose stimulates insulin secretion, whereas kisspeptin1 inhibits insulin secretion from pancreatic β-cells (5). Regarding locomotor activity, research with Kiss1R KO (knock-out) mice has shown that in the absence of KISS1R signaling, locomotor activity is dramatically reduced and accompanied by reduction in food intake and energy expenditure. In addition, studies have shown that in the absence of KISS1R signaling, there is increased body weight and impairment of glucose homeostasis in female but not male mice (3).

Kisspeptin and Sexual Attraction

Kisspeptin was also found to enhance activity in parts of the human brain associated with love and sexual arousal. Olfactory and visual signals are central inputs involved in sexual attraction. A recent study demonstrated that kisspeptin enhances brain activity in response to olfactory and visual cues of attraction in healthy men. Due its link to attraction, researchers are investigating if kisspeptin therapeutics may have potential to treat psychosexual disorders in addition to common reproductive disorders (6).

Conclusion

The roles for kisspeptin are multi-faceted with involvement in cancer, reproduction, metabolism and attraction. Consequently, there is interest in developing kisspeptin agonists and antagonists as therapeutics for a range of conditions. To support life scientists and researchers studying kisspeptin, Bachem offers a selection of kisspeptin peptides in addition to a comprehensive custom synthesis services.

References

1) W.Dhillo. Timeline: Kisspeptins. Lancet Diabetes Endocrinol. 1(1), 12-13 (2013)

2) C.M.Tevisan et al. Kisspeptin/GPR54 system: What do we know about its role in human reproduction? Cell Physio. Biochem. 49, 1259-1276 (2018)

3) K.P.Tolson et al. Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity. J. Clin. Invest. 124(7), 3075-3079 (2014)

4) M.A.Hussain et al. There is kisspeptin – and then there is kisspeptin. Trends Endocrinol. Metab. 26(10), 564-572 (2015)

5) W.Song et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell. Metab. 19(4), 667-681 (2014)

6) L.Yang et al. Kisspeptin enhances brain responses to olfactory and visual cues of attraction in men. JCI Insight. 5(3), e133633 (2020)

The neuropeptide kisspeptin-54, initially named metastin, was first discovered in 1996 as a metastasis suppressor. Subsequently, kisspeptin-54 was found to stimulate gonadotropin-releasing hormone (GnRH) release. The kisspeptins are a family of peptides encoded by the KISS1 gene, which are formed from proteolysis of their common precursor called prepro-kisspeptin (1). Due to involvement in tumor suppression, puberty, reproduction, metabolism and other roles in humans, kisspeptins are of interest for therapeutic applications. Currently, there are two kisspeptins and a kisspeptin analog in Phase II of clinical development as shown in Table 1.

Kisspeptin-10

Massachusetts General Hospital

Phase II

Hyperprolactinemia, Secondary (Hypogonadotropic) Hypogonadism

Kisspeptin-54

Imperial College London

Female Infertility

MVT-602

Myovant Sciences Ltd

Interesting news about peptides in basic research and pharmaceutical development:

An experimental peptide could block Covid-19-MIT News

Researchers gain new insights into pain signaling in the brain-EurekAlert!

New technique has potential to protect oranges from citrus greening-ScienceDaily

Brain cancer CAR T cell therapy guided by scorpion toxin starts first human trial-Genetic Engineering & Biotechnology News

Related Articles

API contract manufacturing: Process, benefits, and partner selection

What is Tag-Assisted Peptide Synthesis (TAPS)?

A mild and sustainable platform for disulfide bond formation in peptide manufacturing using dehydroascorbic acid

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Published Studies

Comprehensive Review on Kisspeptin and Its Role in Reproductive Disordershttps://pmc.ncbi.nlm.nih.gov/articles/PMC4508256/ Kisspeptin Administration Stimulates Reproductive Hormones and Sexual Brain Processing: 2025 Reviewhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12527446/ Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder (JAMA Network Open)https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800937 Exogenous Kisspeptin Administration as a Probe of GnRH Neuronal Function in Idiopathic Hypogonadotropic Hypogonadismhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4255107/ ClinicalTrials.gov – Kisspeptin Administration in Adultshttps://clinicaltrials.gov/study/NCT00914823 Kisspeptin Physiology Across Reproductive Development (NIH Research Project)https://reporter.nih.gov/project-details/8716915 Targeting Hepatic Kisspeptin Receptor Ameliorates Steatosis and Fibrosis in Experimental Liver Diseasehttps://pmc.ncbi.nlm.nih.gov/articles/PMC9106350/ Review Articles Kisspeptins Regulating Fertility: Potential Future Therapeutic Applicationshttps://pmc.ncbi.nlm.nih.gov/articles/PMC12112093/ Kisspeptin in Female Reproduction: From Physiology to Pathophysiologyhttps://gremjournal.com/journal/03-2021/kisspeptin-in-female-reproduction-from-physiology-to-pathophysiology/ Kisspeptin and Endometriosis—Is There a Link?https://pmc.ncbi.nlm.nih.gov/articles/PMC11678265/ The information provided on this page is intended for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease and should not be considered medical advice. This content was generated with the assistance of artificial intelligence (AI) and should be reviewed by a qualified medical professional before publication or clinical use. AI-generated medical content may contain errors, omissions, or outdated information. Kisspeptin is not FDA-approved for any medical indication in the United States. Although clinical research has demonstrated promising effects on reproductive hormone regulation and fertility, its therapeutic use remains investigational. Individual results vary, and no specific outcome or benefit can be guaranteed. Patients should consult a qualified healthcare provider before beginning or changing any medical treatment. R2 Medical Clinic uses medications sourced from compounding pharmacies. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). Unlike FDA-approved medications, compounded drugs have not undergone FDA review for safety, effectiveness, or efficacy through the FDA drug approval process. While 503B outsourcing facilities are registered with and inspected by the FDA and must comply with Current Good Manufacturing Practice (CGMP) requirements, the compounded medications they produce are not individually approved by the FDA. Similarly, compounded medications prepared by 503A pharmacies are not FDA-approved and are primarily regulated by state boards of pharmacy, with FDA oversight under applicable federal law. # Gonadorelin